Search

Your search keyword '"Frederick, Dennie T"' showing total 705 results

Search Constraints

Start Over You searched for: Author "Frederick, Dennie T" Remove constraint Author: "Frederick, Dennie T"
705 results on '"Frederick, Dennie T"'

Search Results

1. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

2. Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

3. Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses

4. Targeting TBK1 to overcome resistance to cancer immunotherapy

5. Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy

7. In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

8. Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation.

9. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice.

11. Landscape of helper and regulatory antitumour CD4+ T cells in melanoma

12. HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors

13. STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming

14. Spatially organized multicellular immune hubs in human colorectal cancer

15. Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma

16. Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era

17. Evolution of delayed resistance to immunotherapy in a melanoma responder

18. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

19. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

22. MAESTRO-Pool Enables Highly Parallel and Specific Mutation-Enrichment Sequencing for Minimal Residual Disease Detection in Cohort Studies

23. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

24. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

25. Toward Minimal Residual Disease-Directed Therapy in Melanoma

26. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

27. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

28. Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence

29. Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines

30. A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

31. Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

36. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

37. Genome‐wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy

38. Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants

39. Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

40. Supplementary Movie 1 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

41. Supplementary Movie 2 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

42. Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

43. Data from Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

44. Supplementary Figure from Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

45. Supplementary Data from Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

46. Abstract 965: Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma

47. Abstract 5709: Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring

48. Data from MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition

49. Supplementary Tables 1 - 3 from Elucidating Distinct Roles for NF1 in Melanomagenesis

50. Supplementary Figure 2 from Elucidating Distinct Roles for NF1 in Melanomagenesis

Catalog

Books, media, physical & digital resources